External reference pricing for medicines in Ukraine: latest trends

Authors

DOI:

https://doi.org/10.14739/2409-2932.2023.3.287758

Keywords:

pharmaceutical preparations, reference prices, external reference pricing, health technology assessment

Abstract

Compared to the previous year, the share of healthcare expenditure in the state budget of Ukraine has decreased, which is associated with increased funding for the security and defense sector. In terms of gross domestic product, healthcare spending has reduced to 2.8 %, which corresponds to the figures for 2019. These circumstances indicate the importance of proper budget utilization, including effectively regulating medicine prices. One of the key elements of rational healthcare budget usage is the development and implementation of external reference pricing (ERP). A well-formulated and implemented ERP policy for pharmaceuticals contributes to improving patient access to essential medicines (EMs).

The aim of this study is to analyze the current status of ERP implementation in Ukraine and provide recommendations for improving this policy.

Materials and methods. During the research process, an analysis of the ERP’s current regulatory framework was conducted, and ERP implementation in Ukraine was assessed according to adherence to the 14 best practice principles of ERP proposed by Sullivan, Kanavos & Kalo in 2015.

Results. In Ukraine, ERP has been introduced for medicines from the National Essential Medicine Lists (NEML) and the “Affordable Medicines” program. The Ministry of Health (MoH) of Ukraine has approved a Register of marginal wholesale prices for medicines purchased with state budget funds and subject to price regulation. Currently, the register includes 1239 medicinal products, of which 1233 are from NEML and 6 have undergone Health Technology Assessment (HTA). Approximately 58 % of medicines have a set price through ERP, 24 % are regulated by internal reference pricing (IRP), and nearly 18 % have declared prices. This indicates a lack of uniformity in approaches to price regulation for medicines and requires further improvements. According to the latest update of the Register of medicines for reimbursement under the state medical guarantees program, there are 486 medicines, including 72 insulins and 21 immunosuppressive medicines (184 medicines are provided with co-payment). Different approaches, including different reference countries and price calculation algorithms, are applied for the price regulation of medicines in NEML and the “Affordable Medicines” program. An assessment of the implementation of the ERP system in Ukraine based on the 14 best practice principles of ERP proposed by Sullivan, Kanavos & Kalo in 2015 showed that the current policy does not adhere to all principles.

Conclusions. The analysis revealed different approaches to pricing for medicines NEML and the “Affordable Medicines” program, indicating the need for harmonizing pricing policies for different lists. The adoption of a unified positive list can contribute to improving pricing policies and efficient resource utilization. Collecting, disseminating, and exchanging data on drug prices is crucial to support transparency in pricing and its control. Regular monitoring of prices in the market will help ensure compliance with pricing policies and take appropriate measures in case of violations. The implementation of a unified pricing regulation policy for medicines in Ukraine is an important step towards European integration and compliance with international standards.

Author Biographies

L. I. Kucherenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD, DSc, Professor, Head of the Department of Pharmaceutical, Organic and Bioorganic Chemistry

I. V. Nizhenkovska, Bogomolets National Medical University, Kyiv, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Medicinal Chemistry and Toxicology, Honored Worker of Science and Engineering of Ukraine

N. V. Sholoiko, Bogomolets National Medical University, Kyiv, Ukraine

PhD, Associated Professor of the Department of Organization and Economy of Pharmacy

L. O. Hala, Bogomolets National Medical University, Kyiv, Ukraine

PhD, DSc, Professor of the Department of Organization and Economy of Pharmacy

N. O. Datsiuk, Bogomolets National Medical University, Kyiv, Ukraine

PhD, Associated Professor of the Department of Organization and Economy of Pharmacy

References

World Health Organization. (2022). Access to essential medicines. Technical Brief: Pharmaceutical pricing Policy. WHO South-East Asia Region. https://www.who.int/publications/i/item/9789290209874

Ministry of Finance of Ukraine. (2020). Derzhavnyi biudzhet 2020 [Budget execution 2020]. https://mof.gov.ua/uk/current-year-budget-information

Pressluzhba "Shchotyzhnevyka Apteka". (2021). Holovnyi koshtorys krainy - 2022: osnovni pokaznyky ta vydatky na okhoronu zdorovia. Shchotyzhnevyk Apteka, (49), 12-13. https://www.apteka.ua/article/621687

Dmytryk, K. (2022). Derzhbiudzhet - 2023: vydatky na okhoronu zdorovia v biudzheti voiennoho chasu. Shchotyzhnevyk Apteka, (45-46). https://www.apteka.ua/article/651969

World Health Organization. (2020, September 28). WHO guideline on country pharmaceutical pricing policies. https://www.who.int/publications/i/item/9789240011878

Kanavos, P. G., Tzouma, V., Fontrier, A-M., Kamphuis, B., Parkin, Colville G., & Saleh, S. (2018). Pharmaceutical pricing and reimbursement in the Middle East and North Africa region. The London school of economics and political science. https://www.lse.ac.uk/business/consulting/assets/documents/the-implementation-of-external-reference-pricing-within-and-across-country-borders.pdf

Kanavos, P., Fontrier, A.-M., Gill, J., & Kyriopoulos, D. The Implementation of External Reference Pricing within and across Country Borders. (2017). London School of Economics. https://www.lse.ac.uk/business/consulting/assets/documents/the-implementation-of-external-reference-pricing-within-and-across-country-borders.pdf

Cabinet of Ministers of Ukraine. (2009, March 25). Natsionalnyi perelik osnovnykh likarskykh zasobiv [National List of Essential Medicines (No. 333)]. https://zakon.rada.gov.ua/laws/show/333-2009-п#n15

Cabinet of Ministers of Ukraine. (2021, December 29). Deiaki pytannia realizatsii prohramy derzhavnykh harantii medychnoho obsluhovuvannia naselennia u 2022 rotsi (No. 1440). https://zakon.rada.gov.ua/laws/show/1440-2021-п#Text

Cabinet of Ministers of Ukraine. (2019, February 27). Deiaki pytannia reimbursatsii likarskykh zasobiv (No. 135). https://zakon.rada.gov.ua/laws/show/135-2019-%D0%BF?lang=en#Text

Cabinet of Ministers of Ukraine. (2019, April 3). Pro referentne tsinoutvorennia na deiaki likarski zasoby, shcho zakupovuiutsia za biudzhetni koshty (No. 426). https://zakon.rada.gov.ua/laws/show/426-2019-п#Text

Cabinet of Ministers of Ukraine. (2022, October 4). Pro vnesennia zmin do deiakykh postanov Kabinetu Ministriv Ukrainy shchodo referentnoho tsinoutvorennia na deiaki likarski zasoby, shcho zakupovuiutsia za biudzhetni koshty (No. 1117). https://zakon.rada.gov.ua/laws/show/1117-2022-п#Text

Ministry of Health of Ukraine. (2022, October 5). Pro referentne tsinoutvorennia na deiaki likarski zasoby, shcho zakupovuiutsia za biudzhetni koshty (No. 1809). https://zakon.rada.gov.ua/laws/show/z1271-22#Text

Cabinet of Ministers of Ukraine. (2014, July 2). Pytannia deklaruvannia zminy optovo-vidpusknykh tsin na likarski zasoby (No. 240). https://zakon.rada.gov.ua/laws/show/240-2014-п#Text

Ministry of Health of Ukraine. (2022, November 1). Pro zatverdzhennia Reiestru vidomostei shchodo hranychnykh optovo-vidpusknykh tsin na deiaki likarski zasoby, shcho zakupovuiutsia za biudzhetni koshty ta pidliahaiut referentnomu tsinoutvorenniu, stanom na 1 liutoho 2023 roku (No. 408). https://zakon.rada.gov.ua/rada/show/v1963282-22#Text

Ministry of Health of Ukraine. (2023, February 21). Pro zatverdzhennia Reiestru likarskykh zasobiv, yaki pidliahaiut reimbursatsii za prohramoiu derzhavnykh harantii medychnoho obsluhovuvannia naselennia, stanom na 14 liutoho 2023 roku (No. 351). https://zakon.rada.gov.ua/rada/show/v0351282-23#Text

Pharmaceutical Pricing and Reimbursement Policies. (n.d.). European medicine price database (EURIPID). https://ppri.goeg.at/euripid

Verkhovna Rada of Ukraine. (2022, April 1). Pro zakhyst interesiv osib u sferi intelektualnoi vlasnosti pid chas dii voiennoho stanu, vvedenoho u zviazku iz zbroinoiu ahresiieiu Rosiiskoi Federatsii proty Ukrainy (No. 2174-IX). https://zakon.rada.gov.ua/laws/show/2174-20#Text

Downloads

Published

2023-11-03

How to Cite

1.
Kucherenko LI, Nizhenkovska IV, Sholoiko NV, Hala LO, Datsiuk NO. External reference pricing for medicines in Ukraine: latest trends. Current issues in pharmacy and medicine: science and practice [Internet]. 2023Nov.3 [cited 2024Dec.3];16(3):272-6. Available from: http://pharmed.zsmu.edu.ua/article/view/287758